Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Fernando Gutierrez Pereyra (Barcelona, Spain), Fernando Gutiérrez-Pereyra, Vicente Plaza, Concepción Fernández-Rodríguez, Carlos Melero, Borja G. Cosío, Luis Manuel Entrenas, Luis Pérez de Llano, Eduard Tarragona, Rosa Palomino, Antolín López-Viña. Validation of the ’test of the adherence to inhalers’ (TAI) for asthma and COPD patients. Eur Respir J 2015; 46: Suppl. 59, 5012

Member's Comments

No comment yet.

Related content which might interest you: Difference between asthma and COPD patients in adherence and non-adherence patterns to inhaler devices Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Clinical characteristics, pulmonary function, and response to beta2-agonist: Patients with asthma vs. patients with asthma/COPD overlap syndrome Source: Annual Congress 2013 –Asthma at the bedside Year: 2013 The influence of bronchial asthma as a comorbidity of COPD on the COPD assessment test (CAT) Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 The parameters that may affect inhalation therapy success in elderly COPD and asthma patients Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Real life assessment of inhaler use and acute exacerbations in 2935 COPD patients Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Outcomes in patients with COPD during a 3 year follow-up Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Pneumonia risk in COPD patients on long term inhaled corticosteroids – Data from the European COPD audit<% Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Efficacy of indacaterol/glycopyrronium (IND/GLY) versus salmeterol/fluticasone (SFC) on exacerbations and health status in GOLD Group D COPD patients: The FLAME study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 The clinical impact of long-acting bronchodilators in newly diagnosed COPD patients Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 Eosinophilic airway inflammation as a complication of COPD, and the usefulness of ICS on these cases Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Onbrace: A real-life evaluation of indacaterol maintenance treatment for COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Efficacy of early COPD diagnosis and intervention system Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014 Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 QVA149 reduces COPD exacerbation rate in various subgroups of patients: The SPARK study Source: Annual Congress 2013 –New bronchodilators for COPD management Year: 2013 The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS Source: International Congress 2014 – COPD exacerbations Year: 2014 Compare clinical effectiveness of various types of bronchodilators in COPD patients Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Roflumilast added to triple therapy in severe COPD patients with frequent exacerbations: Efficacy and tolerability Source: International Congress 2014 – Markers Year: 2014